![PGM5-AS1 impairs miR-587-mediated GDF10 inhibition and abrogates progression of prostate cancer | Journal of Translational Medicine | Full Text PGM5-AS1 impairs miR-587-mediated GDF10 inhibition and abrogates progression of prostate cancer | Journal of Translational Medicine | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs12967-020-02572-w/MediaObjects/12967_2020_2572_Fig7_HTML.png)
PGM5-AS1 impairs miR-587-mediated GDF10 inhibition and abrogates progression of prostate cancer | Journal of Translational Medicine | Full Text
![Downregulation of PGM5 expression correlates with tumor progression and poor prognosis in human prostate cancer | Discover Oncology Downregulation of PGM5 expression correlates with tumor progression and poor prognosis in human prostate cancer | Discover Oncology](https://media.springernature.com/lw685/springer-static/image/art%3A10.1007%2Fs12672-022-00525-x/MediaObjects/12672_2022_525_Fig2_HTML.png)
Downregulation of PGM5 expression correlates with tumor progression and poor prognosis in human prostate cancer | Discover Oncology
![PGM5 expression is downregulated in breast cancer tissues. (a–c) PGM5... | Download Scientific Diagram PGM5 expression is downregulated in breast cancer tissues. (a–c) PGM5... | Download Scientific Diagram](https://www.researchgate.net/publication/351030641/figure/fig2/AS:1080288050450499@1634572150395/PGM5-expression-is-downregulated-in-breast-cancer-tissues-a-c-PGM5-expression-values.jpg)
PGM5 expression is downregulated in breast cancer tissues. (a–c) PGM5... | Download Scientific Diagram
![PGM5 is a promising biomarker and may predict the prognosis of colorectal cancer patients | Cancer Cell International | Full Text PGM5 is a promising biomarker and may predict the prognosis of colorectal cancer patients | Cancer Cell International | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs12935-019-0967-y/MediaObjects/12935_2019_967_Fig1_HTML.png)